Stock listing
Tiumbio Co., Ltd.
Selected listing: 321550 · KRX · KRW · KR
Tiumbio Co., Ltd. (KRX:321550), Health Technology. Latest release May 31, 2026: TiumBio to Present Phase 2a Interim Data Highlighting Differentiated Clinical…
- Ticker
- KRX:321550
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW
About Tiumbio Co., Ltd.
Tiumbio Co., Ltd. is a public company listed under the ticker 321550 in the Korean market. Tiumbio is focused on its core business activities, contributing to its presence in the industry.
Latest news from Tiumbio Co., Ltd.
TiumBio to Present Phase 2a Interim Data Highlighting Differentiated Clinical Profile for Tosposertib(TU2218) plus Pembrolizumab in First-Line R/M HNSCC at ASCO 2026
May 31, 2026
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids
May 7, 2025
TiumBio's Partner Hansoh Pharma Expands Indications for Merigolix (HS-10518) with Initiation of ART (Assisted Reproductive Technology) Development
March 20, 2025